跳至主要内容
临床试验/NL-OMON46319
NL-OMON46319已完成不适用

A Randomized Clinical Trial to Assess the Efficacy of Adjunctive Closed Loop Control Versus Sensor-Augmented Pump Therapy in the Management of Type 1 Diabetes - the International Diabetes Closed Loop (iDCL) Trial

Academisch medisch centrum0 个研究点目标入组 34 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Diagnosis of type 1 diabetes for at least one year and using insulin for at least 1 year
  • Use of an insulin pump for at least 6 months
  • Age >= 18
  • HbA1c level <10.5% at screening; if HbA1c <6.0% then total daily insulin must be >=0.5 U/kg
  • Access to internet and cell phone service at home

排除标准

  • Medical need for chronic acetaminophen
  • Introduction of any glucose-lowering agent (such as Pramlintide, Metformin, GLP-1, Liraglutide, SGLT2 inhibitors) within the three months prior to enrollment
  • Hemophilia or any other bleeding disorder
  • More than one diabetic ketoacidosis (DKA) in the past 6 months
  • More than one severe hypoglycemia in the past 6 months
  • Use of a closed-loop system within the last month prior to enrollment
  • Employed by, or having immediate family members employed by TypeZero Technologies

研究者

相似试验